Drug – bio-affecting and body treating compositions – Effervescent or pressurized fluid containing – Organic pressurized fluid
Patent
1997-02-07
2000-10-03
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Effervescent or pressurized fluid containing
Organic pressurized fluid
424426, A61K 912
Patent
active
061269190
ABSTRACT:
Methods, compounds, and medicinal formulations utilizing biocompatible polymers for delivery of a drug, particularly for solubilizing, stabilizing and/or providing sustained release of drug from topical, implantable, and inhalation systems. Many of the methods, compounds, and medicinal formulations are particularly suitable for oral and/or nasal inhalation and use polymers of the formula --[X--R.sup.1 --C(O)]-- wherein each R.sup.1 is an independently selected organic group that links the --X-- group to the carbonyl group, and each X is independently oxygen, sulfur, or catenary nitrogen.
REFERENCES:
patent: 2457238 (1948-12-01), Hunter et al.
patent: 3079299 (1963-02-01), Heilig
patent: 3755558 (1973-08-01), Scribner
patent: 3773919 (1973-11-01), Albert et al.
patent: 3816612 (1974-06-01), Schmidt et al.
patent: 3887699 (1975-06-01), Yolles
patent: 3933825 (1976-01-01), Fiscella et al.
patent: 4010196 (1977-03-01), Tsuk
patent: 4011312 (1977-03-01), Reuter et al.
patent: 4683288 (1987-07-01), Tanaka et al.
patent: 4728721 (1988-03-01), Yamamoto et al.
patent: 4732763 (1988-03-01), Beck et al.
patent: 4801739 (1989-01-01), Franz et al.
patent: 4849228 (1989-07-01), Yamamoto et al.
patent: 4851211 (1989-07-01), Adjei et al.
patent: 4869899 (1989-09-01), Burghart et al.
patent: 4897268 (1990-01-01), Tice et al.
patent: 4981850 (1991-01-01), Wade
patent: 4997643 (1991-03-01), Emmett et al.
patent: 5236702 (1993-08-01), Ritter et al.
patent: 5300255 (1994-04-01), Campbell et al.
patent: 5384133 (1995-01-01), Boyes
patent: 5399353 (1995-03-01), Bartnik et al.
patent: 5424063 (1995-06-01), Cardin et al.
patent: 5478921 (1995-12-01), Roby et al.
patent: 5480868 (1996-01-01), Kamei et al.
patent: 5482717 (1996-01-01), Fues et al.
patent: 5536445 (1996-07-01), Campbell et al.
patent: 5538721 (1996-07-01), Babcock et al.
patent: 5567431 (1996-10-01), Vert et al.
patent: 5569450 (1996-10-01), Duan et al.
patent: 5594091 (1997-01-01), Igari et al.
patent: 5618911 (1997-04-01), Kimura et al.
patent: 5631015 (1997-05-01), Bezwada et al.
patent: 5633002 (1997-05-01), Stricker et al.
patent: 5648096 (1997-07-01), Gander et al.
patent: 5653992 (1997-08-01), Bezwada et al.
patent: 5665394 (1997-09-01), Igari et al.
patent: 5672659 (1997-09-01), Shalaby et al.
patent: 5874064 (1999-02-01), Edwards et al.
H.O. Alpar et al., "Preparation and Characteristics of Gentamicin-Containing Poly (Lactide-Co-Glycolide) Microspheres for Lung Targeting", J. Pharmacy & Pharmacologyy, 44 1082 (Dec. 1992).
M. Asano et al., "Biodegradability of a hot-pressed poly(lactic acid) formulation with controlled release of LH-RH agonist and its pharmacological influence on rat prostate", Makromol. Chem., Rapid Commun., 6, 509-513 (1985).
M. Asano et al., "In vivo controlled release of luteinizing hormone-releasing hormone agonist from poly (DL-lactic acid) formulations of varying degradation pattern", Int'l. J. Pharm., 67, 67-77 (1991).
D. Bendix, "Some Remarks on the Broad Molecular Weight Distribution of Poly(D,L-Lactide-co-Glycolides) with Low INH Viscosities", Proceed. Intern. Symp. Control. Rel. Bioact. Mater., 16, 505-506 (1989).
S. Berge et al., "Pharmaceutical Salts", J. Pharm. Sci., 66, 1-19 (Jan. 1977)
R. Bodmeier et al., "The effect of the addition of low molecular weight poly(DL-lactide) on drug release from biodegradable poly(DL-lactide) drug delivery systems", Int'l. J. Pharm., 51, 1-8 (1989).
A. Carrio et al., "Preparation and degradation of surfactant-free PLAGA microspheres", J. Controlled Release, 37, 113-121 (1995).
N. Celebi et al., "The preparation and evaluation of salbutamol sulphate containing poly(lactic acid-co-glycolic acid) microspheres with factorial design-based studies", Int'l. J. Pharm., 136, 89-100 (1996).
P.P. DeLuca et al., "Biodegradable Polyesters for Drug and Polypeptide Delivery", Polymeric Delivery Systems; ACS; Chapter 4, 53-77 (1993).
G.A. Digenis et al., "Peptidyl Carbamates as Novel Elastase Inhibitos: Lung Delivery by Polyglycolic Acid Microspheres", Pharm. Res., 3, Abstract No. 85 (Oct. 1986).
M. Dittrich et al., "Purification of biodegradable polymers and oligomers of aliphatic hydroxy acids", Abstract of Czech Patent No. CZ 278181 (Sep. 15, 1993)--Abstract only: CA122(16):188468y.
S.E. Dunn et al., "Studies on In-Vitro Uptake by Kupffer Cells and the In-Vivo Biodistribution of a Range of Novel Polymeric Colloids", J. Pharmacy & Pharmacology, 44, 1082 (Dec. 1992).
N. Erden et al., "Factors influencing release of salbutamol sulphate from poly(lactide-co-glycolide) microspheres prepared by water-in-oil-in-water emulsion technique", Int'l. J. Pharm., 137, 57-66 (1996).
H. Fukazaki et al., "Synthesis of Copoly (D,L-Lactic Acid) with Relatively Low Molecular Weight and In Vitro Degradation", Eur. Polym. J., 25, 1019-1026 (1989).
B. Guiziou et al., "Investigation of in-vitro release characteristics of NSAID-loaded poly lactic acid microspheres", J. Microencapsulation, 13, 701-708 (1996).
P.K. Gupta et al., "Development and Characterization of Aerosol Formulations of Biodegradable Microspheres for Targeted Delivery to the Lungs", Pharm. Res., 7, Abstract No. PT 6055 (Sep. 1990).
K. Jamshidi et al., "Thermal characterization of polylactides", Polymer, 29, 2229-2234 (Dec. 1988).
I. Kaetsu et al., "Biodegradable Implant Composited for Local Therapy", J. Controlled Release, 6, 249-263 (1987).
K. Kimura et al., "Acid terminal-blocked poly(lactic acid) with good hydrolysis resistance", abstract of Japanese Patent No. 07316273 (Dec. 5, 1995)--Abstract only: CA124(16):203400g.
K. Kimura et al., "Polylactic acids and/or their copolymers", abstract of Japanese Patent No. 07316272 (Dec. 5, 1995)--Abstract only: CA124(12):147775u.
M. Kulkarni et al., "Characterization of Aerosol Formulations of Biodegradable Microspheres", Pharm. Res, 8, Abstract No. PT 6013 (Oct. 1991).
M. Kulkarni et al., "Formulation of PLCA Microspheres as a Suspension Metered Dose Inhaler: Effect of Formulation Variables", Pharm. Res, 11, Abstract No. PDD 7141 (Oct. 1994).
M. Kulkarni et al., "In-Vitro and In-Vivo Testing of Indium Labeled Poly (D,L-Lactide-Co-Glycolide) Microsphere Metered Dose Inhalers", Pharm. Res, 11, Abstract No. PDD 7149 (Oct. 1994).
M. Kulkarni et al., "Stability of PLGA Microsphere Metered Dose Inhaler Formulations", Pharm. Res., 11, Abstract No. PDD 7150 (Oct. 1994).
Y-L. Lai et al., "Sustained Bronchodilation with Isoproterenol Poly(Glycolide-co-Lactide) Microspheres", Pharm. Res., 10, 119-125 (1993).
J.G.P. Lim et al., "Studies of Hydrophobic Microspheres for Controlled Pulmonary Drug Delivery", J. Pharmacy & Pharmacology, 41, 8P (Dec. 1989).
L. Masinde et al., "Nebulization of Poly (Lactic Acid) Microspheres From Aqueous Suspension", Pharm. Res., 8, Abstract No. PT6150 (Oct. 1991).
L. Masinde et al., "Aerosolized Aqueous Suspensions of Poly(L-Lactic Acid) Microspheres", Int'l. J. Pharm, 100, 123-131 (1993).
S. Nagata et al., "Pharmaceutical dosage form design of copoly(lactic/glycolic acid) microspheres. Mechanism of in vitro release of gentamicin", Yakugaku Zasshi, 114, 1005-1014 (1994). Abstract only. CA 122:196760.
K. Nakamura et al., "Controlled release of poly-D-L-lactic acid containing bleomycin", Anti-Cancer Drugs, 6, 483-487 (1995).
K.H. Oh et al., "Plasticization of biodegradable films and microspheres with low molecular weight polymeric fractions", J. Pharm. Sci., 76, Abstract No. N 03-W-18 (Nov. 1987).
E.A. Poyner et al., "A comparative study on the pulmonary delivery of tobramycin encapsulated into liposomes and PLA microspheres following intravenous and endotracheal delivery", J. Controlled Release, 35, 41-48 (1995).
S. Ramanathan et al., "Controlled Release of Amiodarone from Poly L-Lactic Acid Microspheres", Pharm. Res., 10, Abstract No. PDD 7400 (Oct. 1993).
K.M. Scholsky et al., "Characterization of Copolymers Fractionated Using Supercritical Fluids", J. Applied Polymer Science, 33, 2925-2934 (1987).
J.W. Tom et al., "Precipitation of Poly(L-lactic acid) and Compositie Poly(L-lactic acid)-Pyrene Particles by Rapid Expansion of Supercritical Solutions", J. Supercritical Fluids,
Duan Daniel C.
Leach Chester L.
Perman Craig A.
Schallinger Luke E.
Schultz David W.
3M Innovative Properties Company
Fubara B.
Howard MarySusan
Page Thurman K.
Ringsred Ted K.
LandOfFree
Biocompatible compounds for pharmaceutical drug delivery systems does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biocompatible compounds for pharmaceutical drug delivery systems, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biocompatible compounds for pharmaceutical drug delivery systems will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-192233